Sunshine Biopharma market cap SBFM

Share price times shares outstanding: what the whole company sells for, since 2011.

Sunshine Biopharma is worth $581.6K at the close on Oct 23, 2026, at $0.15 a share.

That is down 93% over the last year and down 95% over five years.

Its highest close in our data was $43M in Apr 2022.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$581.6K	$581.6K	$6.5M	−91%
2025	$6.2M	$3.4M	$9.5M	+1%
2024	$6.1M	$835.4K	$14.3M	−12%
2023	$7M	$6.1M	$25.7M	−52%
2022	$14.5M	$4.5M	$43M	+92%
2021	$7.5M	$1.4M	$24.4M	+477%
2020	$1.3M	$13K	$1.8M	+1907%
2019	$65K	$23.3K	$408.2K	−83%
2018	$387.8K	$204.1K	$3.2M	−86%
2017	$2.7M	$411.8K	$3.6M	+298%
2016	$686.4K	$251K	$1.2M	+54%
2015	$447K	$99.7K	$942.9K	−7%
2014	$482.4K	$396.2K	$3.1M	−80%
2013	$2.4M	$2.1M	$5.6M	−54%
2012	$5.3M	$1.6M	$7.1M	+209%
2011	$1.7M	$1.5M	$10M	n/a

Companies in Drug Manufacturers - General nearest Sunshine Biopharma's size, closest first, today.

Company	Market cap
SBFMSunshine Biopharma	$581.6K
DCOYDecoy Therapeutics	$635.5K
JAGXJaguar Health	$702.9K
LABTLakewood-Amedex Biotherapeutics	$734.6K
NXTSNexentis Technologies	$761.8K
VBIOValion Bio	$834.3K
ARTLArtelo Biosciences	$1.3M
LNAILunai Bioworks	$1.5M
GNPXGenprex	$1.5M
GOVXGeoVax Labs	$1.5M
ONCOOnconetix	$1.7M
Peer median	$1.1M